Cite
Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma
MLA
Maria Gule-Monroe, et al. “Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma.” JCO Precision Oncology, Nov. 2018, pp. 1–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dbb2fd28227df32aafc26c5fc71a0b0b&authtype=sso&custid=ns315887.
APA
Maria Gule-Monroe, Priyanka C. Iyer, Maria E. Cabanillas, Vivek Subbiah, Gilbert J. Cote, Jacquelin Bui-Griffith, Adam S. Garden, Neil D. Gross, Marie Claude Hofmann, Kenneth R. Hess, Mark Zafereo, Naifa L. Busaidy, Brandon Gunn, Renata Ferrarotto, Michelle D. Williams, Heath D. Skinner, Ramona Dadu, & Tao Hai. (2018). Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precision Oncology, 1–11.
Chicago
Maria Gule-Monroe, Priyanka C. Iyer, Maria E. Cabanillas, Vivek Subbiah, Gilbert J. Cote, Jacquelin Bui-Griffith, Adam S. Garden, et al. 2018. “Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma.” JCO Precision Oncology, November, 1–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dbb2fd28227df32aafc26c5fc71a0b0b&authtype=sso&custid=ns315887.